Arzerra
Showing 26 - 50 of 53
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial in Houston (biological, drug, other)
Recruiting
- B Acute Lymphoblastic Leukemia
- B Lymphoblastic Lymphoma
- Blinatumomab
- +12 more
-
Houston, TexasM D Anderson Cancer Center
Feb 21, 2021
Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United
Recruiting
- Relapsing Multiple Sclerosis
- +2 more
- Autologous Hematopoietic Stem Cell Transplantation
- Best Available Therapy (BAT)
-
Palo Alto, California
- +20 more
Jan 25, 2023
Chronic Lymphocytic Leukemia, B-Cell Non-Hodgkin's Lymphoma Trial in Philadelphia (Bendamustine, Pentostatin, Ofatumumab)
Terminated
- Chronic Lymphocytic Leukemia
- B-Cell Non-Hodgkin's Lymphoma
- Bendamustine
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
May 23, 2018
Leukemia, Precursor-B Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Houston (Cytarabine, Daunorubicin,
Terminated
- Leukemia
- +3 more
- Cytarabine
- +12 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 9, 2018
Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia Trial in United States
Completed
- Chronic Lymphocytic Leukemia
- +9 more
- Cyclophosphamide
- +3 more
-
Scottsdale, Arizona
- +3 more
Aug 20, 2018
Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Columbus (drug, other,
Completed
- Chronic Lymphocytic Leukemia
- +3 more
- Dinaciclib
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 15, 2018
Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Ofatumumab)
Terminated
- Chronic Lymphocytic Leukemia
-
Duarte, California
- +79 more
Aug 5, 2019
Leukaemia, Lymphocytic, Chronic Trial in Australia, New Zealand, United States (Ofatumumab)
Completed
- Leukaemia, Lymphocytic, Chronic
- Ofatumumab
-
La Jolla, California
- +3 more
Nov 8, 2017
Non-Hodgkin's Lymphoma Trial in Worldwide (Ofatumumab, Rituximab)
Terminated
- Non-Hodgkin's Lymphoma
- Ofatumumab
- Rituximab
-
Anchorage, Alaska
- +154 more
Apr 16, 2018
Chronic Lymphocytic Leukemia (CLL) Trial (Dinaciclib, Ofatumumab)
Completed
- Chronic Lymphocytic Leukemia (CLL)
- (no location specified)
Feb 17, 2017
Chronic Lymphatic Leukemia Trial in Germany (Ofatumumab)
Completed
- Chronic Lymphatic Leukemia
-
Heidelberg, Baden-Württemberg, Germany
- +10 more
Sep 16, 2016
Chronic Lymphocytic Leukemia (CLL), Leukaemia, Lymphocytic, Chronic Trial in Worldwide (Ofatumumab, Bendamustine)
Completed
- Chronic Lymphocytic Leukemia (CLL)
- Leukaemia, Lymphocytic, Chronic
- Ofatumumab
- Bendamustine
-
Tuscon, Arizona
- +32 more
Nov 22, 2016
Waldenström Macroglobulinemia Trial in Buffalo, New York (biological, drug, other)
Terminated
- Waldenström Macroglobulinemia
- ofatumumab
- +2 more
-
Buffalo, New York
- +1 more
May 3, 2016
Diffuse Large B-cell Lymphoma Trial in Singapore (O-ICE (ofatumumab, Ifosfamide, Carboplatin, Etoposide))
Completed
- Diffuse Large B-cell Lymphoma
- O-ICE (ofatumumab, Ifosfamide, Carboplatin, Etoposide)
-
Singapore, SingaporeNational Cancer Centre
Mar 21, 2016
Stage III Melanoma, Stage IV Melanoma Trial in Vienna (Ofatumumab, Ofatumumab plus Dacarbazine)
Completed
- Stage III Melanoma
- Stage IV Melanoma
- Ofatumumab
- Ofatumumab plus Dacarbazine
-
Vienna, Austria
- +1 more
Oct 4, 2015
Chronic Lymphocytic Leukemia Trial in Charleston, Greenville (Ofatumumab, Lenalidomide)
Completed
- Chronic Lymphocytic Leukemia
-
Charleston, South Carolina
- +1 more
Nov 2, 2015
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocyctic Leukemia Trial in Columbus (PCI-32765,
Completed
- B-cell Chronic Lymphocytic Leukemia
- +3 more
-
Columbus, OhioThe Ohio State University
May 28, 2015
Phase IV Observational Study in Chronic Lymphocytic Leukemia
Completed
- Leukaemia, Lymphocytic, Chronic
- Arzerra
- (no location specified)
Jul 3, 2014